200 related articles for article (PubMed ID: 33592662)
1. [EBV-positive MTX-associated lymphoproliferative disorder and Ig M myeloma in rheumatoid arthritis].
Wernecke M; Frieling D; Brandl U; Feller A; von Wichert G
Dtsch Med Wochenschr; 2021 Feb; 146(4):262-265. PubMed ID: 33592662
[TBL] [Abstract][Full Text] [Related]
2. CD8(+) T-cell lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis during methotrexate therapy.
Hatachi S; Kunitomi A; Aozasa K; Yagita M
Mod Rheumatol; 2010 Oct; 20(5):500-5. PubMed ID: 20437072
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
Ejima-Yamada K; Oshiro Y; Okamura S; Fujisaki T; Mihashi Y; Tamura K; Fukushige T; Kojima M; Shibuya K; Takeshita M
Virchows Arch; 2017 Feb; 470(2):205-215. PubMed ID: 27864689
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-associated lymphoproliferative disorder with histopathological features of histiocytic necrotizing lymphadenitis.
Kaito S; Goto M; Iguchi M; Okuno Y; Moriyoshi K; Koyama H
Mod Rheumatol Case Rep; 2021 Jan; 5(1):141-144. PubMed ID: 33269654
[TBL] [Abstract][Full Text] [Related]
6. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder.
Sakaguchi R; Fujikawa K; Okamoto M; Matsuo E; Matsumoto K; Uchida T; Shin-Ya K; Nakashima M; Mizokami A; Kawakami A
Intern Med; 2019 Nov; 58(21):3167-3171. PubMed ID: 31292392
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis.
Kikuchi K; Miyazaki Y; Tanaka A; Shigematu H; Kojima M; Sakashita H; Kusama K
Head Neck Pathol; 2010 Dec; 4(4):305-11. PubMed ID: 20676828
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
[TBL] [Abstract][Full Text] [Related]
10. Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate.
Kondo S; Tanimoto K; Yamada K; Yoshimoto G; Suematsu E; Fujisaki T; Oshiro Y; Tamura K; Takeshita M; Okamura S
Virchows Arch; 2013 Apr; 462(4):399-407. PubMed ID: 23494713
[TBL] [Abstract][Full Text] [Related]
11. Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report.
Nomura M; Sumiya R; Ono H; Nagai T; Kumazawa K; Shimizu A; Endo D; Aoyanagi N
World J Surg Oncol; 2021 Jan; 19(1):4. PubMed ID: 33388058
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J
Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761
[TBL] [Abstract][Full Text] [Related]
13. CD8-positive T-cell lymphoproliferative disorder associated with Epstein-Barr virus-infected B-cells in a rheumatoid arthritis patient under methotrexate treatment.
Koji H; Yazawa T; Nakabayashi K; Fujioka Y; Kamma H; Yamada A
Mod Rheumatol; 2016; 26(2):271-5. PubMed ID: 24386983
[TBL] [Abstract][Full Text] [Related]
14. A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders.
Yamakawa N; Fujimoto M; Kawabata D; Terao C; Nishikori M; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Ohmura K; Fujii T; Kitano T; Kondo T; Yurugi K; Miura Y; Maekawa T; Saji H; Takaori-Kondo A; Matsuda F; Haga H; Mimori T
J Rheumatol; 2014 Feb; 41(2):293-9. PubMed ID: 24334644
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis. Role of Epstein-Barr virus infection.
Lioté F; Pertuiset E; Cochand-Priollet B; D'Agay MF; Dombret H; Numéric P; D'Anglejan G; Kuntz D
J Rheumatol; 1995 Jun; 22(6):1174-8. PubMed ID: 7674250
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus, methotrexate, and lymphoma in patients with rheumatoid arthritis and primary Sjögren's syndrome: case series.
Dawson TM; Starkebaum G; Wood BL; Willkens RF; Gown AM
J Rheumatol; 2001 Jan; 28(1):47-53. PubMed ID: 11196542
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-related lymphoproliferative disorder of the lumbar spine origin presenting with severe low-back pain: case report.
Kikuchi N; Uesugi M; Koda M; Shimizu T; Murakami K; Kono M; Tanaka H; Yamazaki M
J Neurosurg Spine; 2018 Nov; 29(5):545-548. PubMed ID: 30168781
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
He J; Williamson L; Cai K; Wong P; Sturgess A; Taper J; Manolios N
Intern Med J; 2022 Oct; 52(10):1717-1723. PubMed ID: 34028145
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
Salloum E; Cooper DL; Howe G; Lacy J; Tallini G; Crouch J; Schultz M; Murren J
J Clin Oncol; 1996 Jun; 14(6):1943-9. PubMed ID: 8656264
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate-associated Lymphoproliferative Disorder: A Rare Differential Diagnosis of Wheezes.
Ujino M; Miyoshi S; Sugimoto N; Arai H; Ota Y; Sasajima Y; Kawamura M; Nagase H; Yamaguchi M; Ohta K
Intern Med; 2019 Jun; 58(12):1759-1764. PubMed ID: 30713294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
